Dupont Jakob
- SEC CIK
- 0001553335
In the past year, 1 open-market sale filing worth $107.1K and no purchases.
Current role at each company
- PYXS Pyxis Oncology, Inc.Directoras of Aug 20, 2026
- BOLT Bolt Biotherapeutics, Inc.Directoras of Jun 11, 2026
- APGN Apexigen, Inc.Directoras of Aug 25, 2023
- ATRA Atara Biotherapeutics, Inc.EVP, Head of R&Das of Mar 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $107.1K
- 1 filing
- Net
- −$107.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dupont Jakob as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)4:30 PM ET | Jun 30 | 2 days | Dupont JakobDirector | SSale | −35.0K | $3.06 | −$107.1K | −47.5%38.7K after | 10b5-1 |
ATRA Atara Biotherapeutics, Inc.
EVP, Head of R&D11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Dupont JakobEVP, Head of R&D | SSale | −5.07K | $3.63 | −$18.4K | −1.7%290.8K after | |
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −4.34K | $4.49 | −$19.5K | −2.7%154.5K after | 2 lots |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −4.12K | $5.03 | −$20.7K | −2.5%158.9K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −3.87K | $5.32 | −$20.6K | −2.3%163.0K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −2.22K | $9.86 | −$21.9K | −1.3%166.9K after | |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Dupont JakobEVP, Head of R&D | SSale | −5.00K | $16.00 | −$80.0K | −5.2%90.6K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −5.00K | $16.01 | −$80.0K | −5.2%90.6K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −5.00K | $17.94 | −$89.7K | −5.2%90.6K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −2.20K | $17.12 | −$37.6K | −2.4%90.6K after | |
| Nov 4, 2021 (view filing) | Nov 2 | 2 days | Dupont JakobEVP, Head of R&D | SSale | −5.00K | $16.41 | −$82.0K | −5.1%92.8K after |